Related Experiment Video
Updated: Nov 18, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Sonopermeation Enhances Uptake and Therapeutic Effect of Free and Encapsulated Cabazitaxel
Sofie Snipstad1, Ýrr Mørch2, Einar Sulheim1
1Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway; Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olav's Hospital, Trondheim, Norway.
Abstract:
Delivery of drugs and nanomedicines to tumors is often heterogeneous and insufficient and, thus, of limited efficacy. Microbubbles in combination with ultrasound have been found to improve delivery to tumors, enhancing accumulation and penetration. We used a subcutaneous prostate cancer xenograft model in mice to investigate the effect of free and nanoparticle-encapsulated cabazitaxel in combination with ultrasound and microbubbles with a lipid shell or a shell of nanoparticles. Sonopermeation reduced tumor growth and prolonged survival (26%-100%), whether the free drug was co-injected with lipid-shelled microbubbles or the nanoformulation was co-injected with lipid-shelled or nanoparticle-shelled microbubbles. Coherently with the improved therapeutic response, we found enhanced uptake of nanoparticles directly after ultrasound treatment that lasted several weeks (2.3 × -15.8 × increase). Neither cavitation dose nor total accumulation of nanoparticles could explain the variation within treatment groups, emphasizing the need for a better understanding of the tumor biology and mechanisms involved in ultrasound-mediated treatment.
Insights
Ultrasound combined with microbubbles enhances drug delivery to tumors, significantly reducing tumor growth and prolonging survival in mice. This approach improves nanoparticle uptake, offering a promising strategy for cancer therapy.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Tumor drug delivery is often insufficient, limiting treatment efficacy.
- Ultrasound and microbubbles can enhance drug penetration and accumulation in tumors.
Purpose of the Study:
- To investigate the efficacy of ultrasound-mediated drug delivery using microbubbles for prostate cancer treatment.
- To evaluate the impact of different microbubble shell compositions (lipid vs. nanoparticle) on drug delivery and therapeutic response.
Main Methods:
- A subcutaneous prostate cancer xenograft mouse model was used.
- Free or nanoparticle-encapsulated cabazitaxel was administered with ultrasound and microbubbles (lipid or nanoparticle shells).
- Tumor growth, survival rates, and nanoparticle uptake were assessed.
Main Results:
- Sonopermeation significantly reduced tumor growth and prolonged survival (26%-100%) across all tested microbubble and drug formulations.
- Enhanced nanoparticle uptake was observed post-ultrasound treatment, persisting for several weeks.
- Treatment variations within groups could not be explained by cavitation dose or total nanoparticle accumulation.
Conclusions:
- Ultrasound and microbubbles effectively improve cabazitaxel delivery and therapeutic outcomes in a prostate cancer model.
- Nanoparticle-encapsulated drugs combined with ultrasound offer a potent strategy for enhanced tumor treatment.
- Further research is needed to elucidate the underlying tumor biology and mechanisms of ultrasound-mediated drug delivery.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Solubility Enhancement
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...

